Clinical Evaluation of Cefuroxime Axetil in Acute Tonsillitis A Double Blind Comparison with Cefaclor Shozo KAWAMURA*(1), Ichiro FURUUCHI and Yoshiyuk
|
|
- なおみ ありはら
- 5 years ago
- Views:
Transcription
1 Clinical Evaluation of Cefuroxime Axetil in Acute Tonsillitis A Double Blind Comparison with Cefaclor Shozo KAWAMURA*(1), Ichiro FURUUCHI and Yoshiyuki TANIGAITO(2), Yutaka FUJIMAKI(3), Takatsugu ITABASHI(4), Hiroshi WATANABE(5), Haruhisa HORIKAWA(6), Yasuya NOMURA, Isuzu KAWABATA and Minoru SHOJI(7), Keiichi ICHIMURA, Meijin SHU and Yasushi MURAKAMI(8), Hirosato MIYAKE and Atsushi SHINKAWA(9), Junichi MATSUKAWA, Shimei KAN and Hideshige KIMURA(10), Makoto SAKAI, Nobuyuki KOMATSU and Mashiko ANDO(11), Tadashi AKITAYA and Yoshiyuki TAMURA(12), Masahiro IIDA and Mutsumi NAKAYAMA(13), Shunkichi BABA, Junichiro SHIMADA, Kaoru SOYANO, Yoshito MORI, Kenji SUZUKI and Mitsuaki INAGAKI(14), Yasuhiko OHYA(15), Jun HONDO and Ippei TAKAGI(16), Masao TSUKIYAMA(17), Tsuyoshi TAKANO(18), Takashi KAWAI(19), Haruji KINOSHITA(20), Takeshi MARUO and Haruo ITO(21), Sadayoshi MORITO and Hiromi ITO(22), Masaki WADA(23), Tsutomu HATANO, Shinji KATO and Toru KITAGAKI(24), Yasuo SUZUKI(25), Shigenobu IWATA, Mikio YAGISAWA and Akihiko TAKASU(26), Masashi YAITA(27), Toru MATSUNAGA, Hitoshi OGINO and Morihiro IRIFUNE(28), Ichiro OHKAWACHI(29), Yoshiaki KAWASAKI(30), Shinichi OKUMURA, Katsumi DOI and Kazuhiko SUGIMOTO(31), Shinji SATO(32), Minoru ISHIDA and Naozo TAYA(33), Masayoshi OZAKI and Masanobu KIN(34), Ryuzo ODA and Hideo MAEDA(35), Toshiyuki MIYOSHI(36), Yasuo HARADA, ouji YAJIN and Katsuhiro HIRAKAWA(37), Shubun TAKEBAYASHI and Hideki WADA(38), Daisuke CHIKUIE(39), Shofu NAKATA(40), Masuhiro NODA(41), Michinori KUROKAWA(42), Yuzuru MURAKAMI(43), Yoshinori KIKUYA(44), Yuko NINOMIYA(45), Masaru OHYAMA and
2 Hiromi YANO(46), Ryuji KIYOTA(47), Eriko TABUCHI(48), Hirofumi MATSUYAMA(49), Kozo FUKAMI(50), Ikuo OHNO(51), Mitsuyoshi NAKASHIMA õ(52), Koichi DEGUCHI(53) A double blind comparative study was performed on cefuroxime axetil (CXM-AX), to evaluate objectively its efficacy, safety and usefulness in acute tonsillitis, using cefaclor (CCL) as the comparator. Either of the drugs was administered in the dose of 250 mg tid., in principle for 7 days. 1. In the evaluation of clinical efficacy, the efficacy rates of CXM-AX and CCL were 90.5 % (95/105) and 88.2 % (90/102), respectively, in the assessment by doctors in charge, and 88.6 % (93/105) and 87.3 % (89/102), respectively, in the assessment by the committee, without statistically significant difference between the two treatment groups. 2. When the bacteriological response was evaluated in each case, the elimination rate was 98.0 % (96/ 98) in CXM-AX group and 98.9 % (91/92) in CCL group, and there was no significant difference between the two groups either in this comparison or in the evaluation on the bacteriological response classified by causative organisms. 3. In overall safety, no significant difference was observed between two treatment groups. Adverse events, all of which were gastrointestinal tract symptoms, were observed in 2.6 % (3/114) in CXM-AX group, and in 2.7 % (3/111) in CCL group. Either in adverse events or abnormal laboratory findings, the difference in incidences was not statistically significant between the two groups. 4. The usefulness rates of CXM-AX and CCL were 93.3 % (98/105) and 91.2 % (93/102), respectively, with no significant difference. The above results suggest that CXM-AX is a very useful drug for the treatment of acute tonsillitis. key words: Cefuroxime axetil, Cefaclor, Acute tonsillitis, Double blind comparative study
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17 Department of Otorhinolaryngology, Juntendo University, School of Medicine, Tokyo 113, Japan Department of Otorhinolaryngology, Dokkyo University, School of Medicine, Shimotsuga , Japan Department of Otorhinolaryngology, Katsunan Hospital, Urayasu , Japan Department of Otorhinolaryngology, Koto Hospital, Tokyo 136, Japan Department of Otorhinolaryngology, Taketani Hospital, Kiyose 204, Japan Horikawa Clinic of Otorhinolaryngology, Tokyo 114, Japan Department of Otorhinolaryngology, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan Department of Otorhinolaryngology, Tokyo Metropolitan Fuchu Hospital, Fuchu 183, Japan Department of Otorhinolaryngology, Tokai University, School of Medicine, Isehara , Japan Department of Otorhinolaryngology, Nihon Kokan Hospital, Kawasaki 210, Japan Department of Otorhinolaryngology, Tokai University, Tokyo Hospital Tokyo 151, Japan Department of Otorhinolaryngology, Kosei Hospital, Tokyo 164, Japan Department of Otorhinolaryngology, Isehara Kyodo Hospital, Isehara , Japan Department of Otorhinolaryngology, Nagoya City University, School of Medicine, Nagoya 467, Japan Department of Otorhinolaryngology, Nagoya Municipal Midori City Hospital, Nagoya 458, Japan Department of Otorhinolaryngology, Nagoya Second Red Cross Hospital, Nagoya 466, Japan Department of Otorhinolaryngology, Tokai Teishin Hospital, Nagoya 460, Japan Department of Otorhinolaryngology, Kasugai City Hospital, Kasugai 486, Japan Department of Otorhinolaryngology, Ichinomiya City Hospital, Ichinomiya 491, Japan Department of Otorhinolaryngology, Atsumi Hospital, Atsumi , Japan Department of Otorhinolaryngology, Showa Hospital, Kounan 483, Japan Department of Otorhinolaryngology, Kainan Hospital, Kaifu 498, Japan Department of Otorhinolaryngology, Kamo Hospital, Toyota 471, Japan Department of Otorhinolaryngology, Toyohashi City Hospital, Toyohashi 440, Japan Department of Otorhinolaryngology, Toyokawa City Hospital, Toyokawa 442, Japan Department of Otorhinolaryngology, Fujita Gakuen Health University, School of Medicine, Toyoake , Japan Department of Otorhinolaryngology, Gamagori City Hospital, Gamagori 443, Japan
18 Department of Otorhinolaryngology, Osaka University, Medical Scho6l, Osaka 553, Japan Department of Otorhinolaryngology, Osaka Central Hospital, Osaka 530, Japan Department of Otorhinolaryngology, Osaka Teishin Hospital, Osaka 543, Japan Department of Otorhinolaryngology, Osaka Rosai Hospital, Sakai 591, Japan Department of Otorhinolaryngology, Otemae Hospital, Osaka 540, Japan Department of Otorhinolaryngology, Suita Municipal Hospital, Suita 564, Japan Department of Otorhinolaryngology, Toyonaka City Hospital, Toyonaka 560, Japan Department of Otorhinolaryngology, Meiwa Hospital, Nishinomiya 663, Japan Department of Otorhinolaryngology, Minoo City Hospital, Minoo 562, Japan Department of Otorhinolaryngology, Hiroshima University, School of Medicine, Hiroshima 734, Japan Department of Otorhinolaryngology, Hiroshima Prefectural Hospital, Hiroshima 734, Japan Department of Otorhinolaryngology, Hiroshima General Hospital, Saeki 738, Japan Department of Otorhinolaryngology, Kure National Hospital, Kure 737, Japan Department of Otorhinolaryngology, Hiroshima Red Cross Hospital, Hiroshima 730, Japan Department of Otorhinolaryngology, Onomichi General Hospital, Onomichi 722, Japan Department of Otorhinolaryngology, Mitsubishi Mihara Hospital, Mihara , Japan Department of Otorhinolaryngology, Chugoku Rosai Hospital, Kure , Japan Department of Otorhinolaryngology, Yoshida general Hospital, Takada , Japan Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University, Kagoshima 890, Japan Department of Otorhinolaryngology, Kagoshima Prefectural Hokusatsu Hospital, Oguchi , Japan Department of Otorhinolaryngology, Ichihino Onsen Hospital, Satsuma , Japan Department of Otorhinolaryngology, Miyanojo Central Hospital, Satsuma , Japan Department of Otorhinolaryngology, Kokubu Central Hospital, Kokubu , Japan Department of Otorhinolaryngology, Kagoshima Prefectural Ohshima Hospital, Naze 894, Japan Department of Pharmacology, Hamamatsu University, School of Medicine, Hamamatsu , Japan Tokyo clinical Research Center, Tokyo 120, Japan
Table 1-1. Criteria for evaluation Table 2. Criteria for bacteriological efficacy Table 1-2. Criteria for evaluation Table 3. Reasons for exclusion and drop-out from evaluation (clinical efficacy) Table
More informationTable 1.Concentration of gatifloxacin (Middle-ear) Table 2.Concentration of gatifloxacin (Paranasal sinuses) Table 3.Concentration of gatifloxacin (Tonsil) Table 4.No.of patients studied Table 5.Background
More informationTable 1 Method of administration Inactive placebo. Table 2 Critoria for overall ef4fficy rating by committee L Severity and scores of main symptoms 1) Acute tonsillitis (Peritonsillids, Peritonsillar abscess)
More informationCHEMOTHERAPY Silver sulfadiazine (T 107) CHEMOTHERAPY Fig. 1 Item of patients Table 1 Criteria of bacteriological efficacy by the Committee xcellent: E Score of infection becomes to 0% at the end of medication.
More informationVOL.31 S-2 CHEMOT HERAPY 101 Table 1 Breakdown of cases Table 2 List of excluded cases Table 3 List of drop-out cases 102 CHEMOT HERAPY JULY 1983 Table 4 Background factors of suppurative otitis media
More informationKey words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the
More informationCHEMOTHERAPY
CHEMOTHERAPY CHEMOTHERAPY VOL.32 S-3 CHEMOTHERAPY 1063 Fig. 1 Chemical structure of AT-2266 1-ethyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyl)- 1, 8-naphthyridine-3-carboxylic acid sesquihydrate AT
More informationTable 1 Classification of female patients with vesical irritating symptom by their signs : Urinary pain with or without other vesical irritability. s
Table 1 Classification of female patients with vesical irritating symptom by their signs : Urinary pain with or without other vesical irritability. s Vesical irritability without urinary Pain. Pyuria 10/
More informationTakeji NISHIKAWA, M. D.*, Takashi HARADA, M. D.** and Tatsuya IZUML M. D. Toshiyuki SUGI, M. D. Hiroshi HANYAKU, M. D. Shun-ichi MIYAKAWA, M. D. and Masaru TANAKA, M. D. Nobuko INAMOTO, M. D. and Hironori
More informationTable 1. Serum and tissue levels after a single oral administrsion of gatiflozacin ND: not detected(0. 05 ug/g or 0. 05 ug/eml) Table 2. Reason for exclusion and dropped out from evaluation VOL.47 NO.10
More informationHisao Takayasu Department of Urology, Faculty of Medicine, University of Tokyo Masaaki Ohkoshi Department of Urology, Tokai University School of Medic
COMPARATIVE CLINICAL EFFECT OF AMIKACIN AND GENTAMICIN ON COMPLICATED URINARY TRACT INFECTIONS BY DOUBLE-BLIND METHOD Tsuneo Nishiura and Yukimichi Kawada Department of Urology, Gifu University School
More informationCHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX
Fig. 1 Chemical structure of CXM-AX NOV. 1986 Fig. 2 Sensitivity distribution of clinical isolates organisms (106 cells/ml) a Smurcus 27 strains d) P.m irabilis 15 strains b Ecol i 27 strains 111.morganii
More informationFig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent
Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Enterococcus faecalis Klebsiella pneumoniae, Morganella
More informationVOL.42 S-1
CHEMOTHERAPY APR. 1994 VOL.42 S-1 CHEMOTHERAPY APR. 1994 Table 1. Criteria for evaluation of clinical efficacy by the Japanese Society of Oral and Maxillo-Facial Surgeons Grades of symptoms and numerical
More informationVOL. 34 S-2 CHEMOTH8RAPY 913
VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(
More information400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
More informationCHEMOTHERAPY
CHEMOTHERAPY VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin CHEMOTHERAPY AUG. 1993 VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin Table 1. Comparative in vitro activity of teicoplanin
More informationFig. 1 Chemical structure of Flurbiprofen Molecular formula : C1S H13 F02 Molecular weight : Chemical name : 2-( 2 -fluoro - 4 -biphenyly1 ) pr
Key words : Flurbiprofen, Acute Upper Respiratory Tract Inflammation, Double-Blind Clinical Evaluation Fig. 1 Chemical structure of Flurbiprofen Molecular formula : C1S H13 F02 Molecular weight : 244.27
More informationKey words: Norfloxacin (NFLX), Infectious enteritis, Double-blind method
Key words: Norfloxacin (NFLX), Infectious enteritis, Double-blind method Fig. 1 Chemical structure Norfloxacin (NFLX) Pipemidic acid (PPA) Fig. 2 Package of test drugs Table 1 Criteria for evaluation
More informationFig. 1 Chemical structure of norfloxacin Table 1. Institutes attended to the study The Department of Dermatology, Defense Medical College The Department of Dermatology, School of Medicine, Teikyo University
More informationFig. 1 Chemical structure of norfioxacin (AM-715)
Fig. 1 Chemical structure of norfioxacin (AM-715) Table 1 Serum and biliary concentration of norfloxacin (AM-715) Table 2 Protocol for clinical evaluation of norfloxacin (AM-715) in the treatment of biliary
More informationCHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
More informationCHEMOTHERAPY JAN Fig. 1 Structure of cephradine
VOL. 23 NO. 1 CHEMOTHERAPY 409 CHEMOTHERAPY JAN. 1975 Fig. 1 Structure of cephradine VOL. 23 NO. 1 CHEMOTHERAPY 411 Table 1 Reason for drop-out 412 CHEMOTHERAPY JAN. 1975 VOl. 23 NO. 1 CHEMOTHERAPY 413
More informationSpecial IssueOncology Nutrition Reviews Proceeding DNA β Nutrition and physical activity and the prevention of cancer Yutaka Taketani Department of Clinical Nutrition, Institute of Health Biosciences,
More informationFig. 1 Chemical structure of KW-1070
Fig. 1 Chemical structure of KW-1070 Fig. 2 Sensitivity distribution of clinical isolates Fig. 4 Sensitivity distribution of clinical isolates Fig. 3 Sensitivity distribution of clinical isolates Fig.
More informationVOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human
CHEMOTHERAPY Fig. 1 Chemical structure of carumonam Disodium(+)-(Z)-CCE1-(2-amino-4-thiazoly1)-2-[[(2S, -(carbamoyloxymethyl)-4-oxo-1-sulfonato-3-azetidinyll -2-oxoethylidene] amino] oxy] acetate 3S)-2
More informationCHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote
aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Proteus mirabilis 3.13, Proteus vulgaris 1.56, Citrobacter freundii 0.39,
More informationTitle 神経因性膀胱にともなう排尿障害に対する塩酸ブナゾシンの臨床効果 - 二重盲検比較試験による検討 - 小柳, 知彦 ; 富樫, 正樹 ; 丸, 彰夫 ; 折笠, 精一 ; 相馬, Author(s) 崎, 淳 ; 安田, 耕作 ; 阿曽, 佳郎 ; 本問, 之夫 ; 三宅, 弘厚生 ; 熊
Title 神経因性膀胱にともなう排尿障害に対する塩酸ブナゾシンの臨床効果 - 二重盲検比較試験による検討 - 小柳, 知彦 ; 富樫, 正樹 ; 丸, 彰夫 ; 折笠, 精一 ; 相馬, Author(s) 崎, 淳 ; 安田, 耕作 ; 阿曽, 佳郎 ; 本問, 之夫 ; 三宅, 弘厚生 ; 熊澤, 淨一 ; 武井, 実根雄 Citation 泌尿器科紀要 (1990), 36(10): 1233-1252
More information04-c-„FŒ{›xŒ¾-4.01
544( 56 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 6 Dec. 25 2003 2. * * Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS 58 6 545( 57 ) 9 5 2003 8 2004 714 565 719 50 20 39 0 9 70 79 44.4 91.7% Escherichia coli
More informationJJRM5005/04.短報.責了.indd
Jpn J Rehabil Med 2013 ; : 319.327 1 2 3 4 5 6 Survey of the Electronic Medical Recoding System Used in Kaifukuki Rehabilitation Wards Hidekazu SUGAWARA, 1 Tetsutaro YAHATA, 2 Hideto OKAZAKI, 3 Mitsuhiro
More information第56巻6号/投稿規定・目次・表2・奥付・背
Feature articlesthe Front of Stroke Management Originals α Imaging protocol for apoplexy of acute phase Masafumi Harada, Kazuhide Yoneda, Naomi Morita, Mayumi Takeuchi, Sonoka Hisaoka, Toshiko Okada,
More informationCHEMOTHERAPY APRIL 1992 Table 2. Concentration of meropenem in human prostatic fluid Table 1. Background of 21 chronic complicated UTI cases * NB + BPH, NB + Kidney tumor, NB + Kidney tuberculosis Table
More information400 CHEMOTHERAPY JAN Table 1 Cases of drop outs
VOL. 23 NO. 1 CHEMOTHERAPY 399 Fig. 1 Stracture of cephradine Chemical name : 7-CD(-)-2-amino-2-(1,4-cyclohexadien-1-y1) -acetamido) -3-methyl-8-oxo-5-thia-1-aza- -bicyclo [4. 2. 0] oct-2-ene-2-carboxylic
More informationindd
12 61 1 2011 原著 1)2)5) 1) 1)2) 1)2)5) 1)3)5) 1)2) 1)2)5) 1)2) 1)2) 2) 2) 4) 1) 1) 2) 3) 4) 5) 2010 10 6 2010 12 6 A Comparative Study of the Effect and Discomfort Produced by Pharyngeal Anesthesia with
More informationCHEMOTHERAPY MAY. 1988
CHEMOTHERAPY MAY. 1988 CHEMOTHERAPY Fig. 1 Chemical structure CHEMOTHERAPY MAY. 1988 VOL.36 5-1 CHEMOTHERAPY CHEMOTHERAPY MAY. 1988 VOL.36 S-1 CHEMOTHERAPY CHEMOTHERAPY MAY. 1988 VOL.36 S-1 CHEMOTHERAPY
More informationCHEMOTHERAPY Table 1 Clinical effect of Sultamicillin
CHEMOTHERAPY CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY Fig. 1 MICs of sultamicillin against respiratory pathogenic Branhamella catarrhalis 62 strains, inoculum size 106CFU/m1 Fig.
More informationSpecial IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them
More informationVOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St
CHEMOTHERAPY VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant Staphylococcus aureus CHEMOTHERAPY Table
More informationudc-3.dvi
49 UDC 371.279.1 3 4 753 1 2 2 1 2 47 6 2005 11 14 50 No.35, 2006 1 1.1 AO 2003 2004 2005 2005 1 1 2005 1998 1999 2002 12 11 2000 SAT ACT Law School Admission Test LSAT Medical College Admission Test MCAT
More informationCHEMOTHERAPY APRIL 1992 VOL. 40 S- 1 Table 1-1. Comparative in vitro activity of meropenem against clinical isolates CNS: coagulase-negative staphylococci CHEMOTHERAPY APRIL 1992 Table 1-2. Comparative
More information第59巻4,5号(10月号)/投稿規定・目次・表2・奥付・背
Special IssuePhysiology, psychology and treatment of eating disorders Reviews Originals Proceeding Case Report ob α α et al. et al et al Control of food intake Kyoichi Kishi, Kazuhito Rokutan, Takeshi
More informationcoccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F
VOL.43 S-1 coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, Flavobacter- Table 1. Concentration of grepafloxacin
More informationCHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus
VOL. 32 S-4 CHEMOTHERAPY Fig. 1 Chemical structure of sodium cefoperazone Fig. 2 Chemical structure of sodium cefoperazone CHEMOTHERAPY JUN. 1984 Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter
More information2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11
1-122013 1 2 1 2 20 2,000 2009 12 1 2 1,362 68.1 2009 1 1 9.5 1 2.2 3.6 0.82.9 1.0 0.2 2 4 3 1 2 4 3 Key words acupuncture and moxibustion Treatment with acupuncture, moxibustion and Anma-Massage-Shiatsu
More informationMicrosoft Word - Supplementary Information(Miura)ver2.docx
[Supplementary Information] Increase in dicentric chromosome formation after a single CT scan in adults Yu Abe 1, Tomisato Miura 2, Mitsuaki A Yoshida 3, Risa Ujiie 1, Yumiko Kurosu 1, Nagisa Kato 1, Atsushi
More informationTable 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates
Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,
More informationFig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo
Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly
More informationCHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates
VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak
More informationEVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAK
EVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAKOTO SAKAI, M.D., ATSUSHI SHINKAWA, M.D. and HIROSATO
More informationFig. 1 Chemical structure Lomefloxacin(LFLX,NY-198) Pipemidic acid(ppa)
Key words : Lomefloxacin (LFLX, NY-198), Infectious enteritis, Double blind method Fig. 1 Chemical structure Lomefloxacin(LFLX,NY-198) Pipemidic acid(ppa) Fig. 2 Package of test drugs LFLX group PPA group
More informationOsamu NEMOTO, M.D. Clinical and Bacteriological Research of Sucrose/ Povidone-Iodine Ointment (U-PASTA kowa) for Pressure Sores and Skin Ulcers Osamu Nemoto Department of Dermatology,Tonan Hosptal
More informationTable 1. Influence of urine ph on MBCs of new quinolones against Escherichia coli NIHJ JC-2 and Pseudomonas aeruginosa 18S; MBCs in urine were compared with those in Miieller-Hinton broth. Table 2. Influence
More information第61巻5・6号(12月号)/特集1頁目(本刷)
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
More information第57巻2号/投稿規定・目次・表2・奥付・背
Feature articlesdiet in a society with a growing elderly population and a low birth rate Original The problems of breastfeeding Kazuhisa Maeda, Ryuji Mitani, Satoko Endo, Yoshika Saijo, and Toshihiro
More information2) Goetz, A., Tsuneishi, N.: Application of molecular filter membranes to the bacteriological analysis of water, J. Am. Water Works Assn., 43 (12): 943-969,1951. 3) Clark, H.F. et al.: The membrane filter
More informationTable 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone
Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone (inoculum size= 106 CFU/ml) (Ĉ-lactamase producer : 2 strains) Fig. 1. Sensitivity distribution of
More information名称未設定-1
Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA
More information1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
More information表紙PDF作成用/PDF表紙作成用
2008 Vol.50 No.1 Jpn J School Health Jpn J School Health Jpn J School Health Jpn J School Health Hosen Junior High School, Okayama City Notre Dame Seishin University Graduate School Jpn J School Health
More informationABSTRACT
Does a Law School Education Increase Lawyers Income and Job Satisfaction?: A Questionnaire Survey of Lawyers who Passed the New Bar Examination and Those who Passed the Old Bar Examination KOYAMA Osamu
More informationKey words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection
Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin
More informationValidation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Ta
Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Tae Kaimoto *', Daisuke Kunii *', Tatsushi Komatsu *2
More informationⅡ. 用語の操作的定義 Ⅲ. 対象と方法 1. 対象 WAM NET 2. 調査期間 : 3. 調査方法 4. 調査内容 5. 分析方法 FisherMann-Whitney U Kruskal-Wallis SPSS. for Windows 6. 倫理的配慮 Vol. No.
研究報告 The Relation Between the Manager s Administrative Abilities Including Business Activities in Visiting Nursing Stations and the Station s Financial Profits Chisato Fujii Akiko Akama Mariko Ohtake Ikuko
More informationFig. 1 Chemical structure of DL-8280
Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.
More informationChanges in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* an
Changes in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* and Yosihiro Amemiya Abstract: This study was designed
More information<95DB8C9288E397C389C88A E696E6462>
2011 Vol.60 No.4 p.332 338 Usefulness of regional education program for dietary salt reduction: Self-monitoring of urinary salt excretion Kenichiro YASUTAKE[1] Kayoko SAWANO[1] Shoko YAMAGUCHI[1] Hiroko
More information622 3) 4 6) ) 8) , ,921 40, ) ) 10 11) ) ) ,434 43, ,18
Vol. 15 No. 2 2006 621 626 Λ1 1959 1995 2004 1959 1995 2004 7 1 2) 1 6 3) 11 Λ1 701-0193 288 E-Mail: takao@mw.kawasaki-m.ac.jp 621 622 3) 4 6) 8 15 7) 8) 2 2 1 1959 34 4,697 401 38,921 40,838 500 9) 9
More informationClinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,
More informationFig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin
Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamine butylbromide during upper gastrointestinal endoscopy.
More information明海大学歯学雑誌 37‐2/1.秦泉寺
J Meikai Dent Med 37, 153 158, 8 153 1 7 5ml /1 min Wong-Baker Face Rating Scale FS 5 1 9. g 3 5ml /1 min, FS 1 66 6ml /1 min FS 5 1 9. g 3 6ml /1 min, FS 3 Two Cases of Xerostomia that Showed an Improvement
More information東洋医学雑誌
Vol.67 No.2 123-130, 2016 Akiyo GUSHI a Chihaya KORIYAMA b Ryo YOSHINAGA c Hiromi YANO c Junichi TSUMAGARI d Eiichi TAHARA c a Gushi Dermatological Clinic, 45-3 Higashiohsyoji, Satsumasendai city, Kagoshima
More information第56巻2号/投稿規定・目次・表2・奥付け・背
Feature articlespsychiatric and psychosomatic symptoms in daily clinical practice Originals Mild depressive disorder and panic disorder Kazuomi Inoue Department of Human Development, Naruto University
More information_原著03_濱田_責.indd
The Journal of the Japan Academy of Nursing Administration and Policies Vol 9, No 2, pp 3140, 2006 原著 看護師の内服与薬業務における 確認エラー に関する検討 Study of Confirmation Errors for Internal Use by Nurses 濱田康代 1) 田口大介 2)
More informationThe Eevaluation One Bottle Type Silane Coupling Agents Masahiro Aida, Hideo Kanaya, Taira Kobayashi, Keiji Utsugizaki, Yoshizumi Murata, Tohru Hayakaw
The Eevaluation One Bottle Type Silane Coupling Agents Masahiro Aida, Hideo Kanaya, Taira Kobayashi, Keiji Utsugizaki, Yoshizumi Murata, Tohru Hayakawa* and Kozo Horie* Abstract: Here is investigated the
More informationDec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)
Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2305(45) 2306(46) THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 Dec. Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2307(47) 2308(48) THE JAPANESE
More information第57巻3号/投稿規定・目次・表2・奥付・背
Feature articlescommon skin diseases of the aged Originals patched PTCH PTCH PTCH PTCH p53 p53 ras p16 INK4a ras Rb/p16 INK4a CDK4 p16 INK4a PTCH p16 INK4a PTEN p16 INK4a BCL2 patched PTCH INK4a PTEN/MMAC1
More information市区町村別平均寿命の全国順位の変化からみた青森県市町村平均寿命の解析
Analysis of the life expectancy at birth of the municipalities in Aomori Prefecture by the change in a nationwide order of the life expectancy at birth Koichi Takemori 1) Seiji Mikami2) Naomi Kudo 1) Yutaka
More informationA 18 B 6 AB p >0.05 A1A2B1B2 A3B3 t p > ο =0 1 =12 =2 0 ο14 10=0ο= ο144 0 ο4041ο64 65ο144 WAIS R Wilcoxon
Vol. 16 No. 2 2006 305 313 WAIS R Rehab Λ1 Λ2 36 WAIS R Rehab Rehabilitation Evaluation of Hall and Baker Rehab 1) 2) WAIS RWechsler Adult Intelligence Scale Revised1990 3) IQ IQ IQ IQ WAIS R Wechsler
More informationNotice Concerning Personnel Changes
To whom it may concern: February 17, 2011 Company name: Mitsubishi Estate Co., Ltd. Representative: Keiji Kimura, President and Chief Securities code: 8802 Contact: Koji Kiyosawa, General Manager, Corporate
More informationepidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia
epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia Table 3. Overall clinical efficacy of cefozopran in
More informationON A FEW INFLUENCES OF THE DENTAL CARIES IN THE ELEMENTARY SCHOOL PUPIL BY Teruko KASAKURA, Naonobu IWAI, Sachio TAKADA Department of Hygiene, Nippon Dental College (Director: Prof. T. Niwa) The relationship
More informationTable 1 Characteristics of the study participants in Imari municipal hospital
Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin
More information06_学術_関節単純X線画像における_1c_梅木様.indd
Arts and Sciences X The formulation of femoral heard measurement corrected enlargement ratio using hip joints X-ray Imaging 1 2 1 1 1 2 Key words: Bipolar Hip Arthroplasty (BHA) Preoperative planning Enlargement
More informationWeb Stamps 96 KJ Stamps Web Vol 8, No 1, 2004
The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale
More information過去26年間のスギ花粉飛散パターンのクラスター分析
117 681 : 2A 2B 2C 2A 2B 2C 2A 2A 2B 2C 2A 2B 2C 2A : DNA Phöbus Blackly 1cm 117 682 2014 1 SYSTAT χ Complete linkage method χ 2A 2B 2C /cm /cm /cm 2A 2B 2C 2A 2B 2C 2A 2B 2C 2 A /cm 2A 2C 117 683 2 2A
More informationJournal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.1 January 2013 Overview History of JABTSJapan Association of Breast and Thyroid Sonology : Dawn of a JABTS Age; The
More informationThe Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi
The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursing Professionals for Diabetic Outpatients Not Using
More informationSuntory Group Notification Concerning Executive Appointments
No.12525 December 10, 2015 Suntory Group Notification Concerning Executive Appointments This is to notify that Suntory Holdings Limited will be implementing their executive appointments. Details Executive
More informationCHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation
CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference
More informationスポーツ選手における日常的トレーニングが味覚に及ぼす影響について
Study on the Type Partition of Hospital Meals in Japan. -Relationship between Foods and Cooking Techniques- Tomoko WATANABE *1, Kunio ISHII *1, Sachiko SUGIZAKI *1, Kanako MURAMATSU *1, Megumi HIGUCHI
More information32Vol. 37(1), Jan Gastroenterol Endosc 1995; 37: Hideyuki AKAI Observation and Evaluation of Esophageal Varices Before and After Sclerothe
32Vol. 37(1), Jan. 1995 Gastroenterol Endosc 1995; 37: 32-8. Hideyuki AKAI Observation and Evaluation of Esophageal Varices Before and After Sclerotherapy by Infrared-Ray Electronic (TREE). Figure 1 The
More informationCompatibility of Ophthalmic Solutions õ1 MUTSUMI END0 õ2, NOBUHIRO YASUNO õ2, KAORI TANAGAM1 õ2, ASAKA ONDA õ2, MIHO IMOT0 õ2, NAOMI IIDA õ2, YUKO SEKINE õ2, NORIO MIYAZAKI õ2, SHIGEKAZU WATANABE õ2, YUKO
More information56 pp , 2005 * ******* *** ** CA CAMA
Title 成人知的障害者の加齢に伴う外観的変化に関する研究 : 知的障害者用外観的老化微候測定法を用いた検討 Author(s) 春日井, 宏彰 ; 菅野, 敦 ; 橋本, 創一 ; 桜井, 和典 ; 片瀬, Citation 東京学芸大学紀要. 第 1 部門, 教育科学, 56: 415-425 Issue Date 2005-03-00 URL http://hdl.handle.net/2309/2097
More informationKey words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination
Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Fig. 1 The value of fungal index and D- arabinitol/creatinine. Fungal index was mesured by Endotoxin D and Endospecy
More informationKey words: pazufloxacin, infectious enteritis, antibacterial activity, fecal concentration, fecal microflora : Table 1-1 Criteria for bacteriological efficacy of pazufloxacin on Shigella spp. and V. cholerae
More informationuntitled
25 th ISTS Organizing Committee Members List General Chairperson Yasunori Matogawa Program Committee Chairperson of the Committee Yasushi Horikawa Co-Chairperson Yuichi Yamaura Co-Chairperson Yasuhiro
More information8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
More informationKey words: Antibodies to Leptospira, Tokyo, Uveitis
Key words: Antibodies to Leptospira, Tokyo, Uveitis Fig. 1 Distribution of Antibody Titers in Age Decade Fig. 3 Distribution of Antibody Titers in each Strain Fig. 2 Correlation between Antibody Titers
More informationFig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,
More information